Abu-Khalaf, M.; Wang, C.; Zhang, Z.; Luo, R.; Chong, W.; Silver, D.P.; Fellin, F.; Jaslow, R.; Lopez, A.; Cescon, T.;
et al. Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism. Cancers 2022, 14, 2872.
https://doi.org/10.3390/cancers14122872
AMA Style
Abu-Khalaf M, Wang C, Zhang Z, Luo R, Chong W, Silver DP, Fellin F, Jaslow R, Lopez A, Cescon T,
et al. Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism. Cancers. 2022; 14(12):2872.
https://doi.org/10.3390/cancers14122872
Chicago/Turabian Style
Abu-Khalaf, Maysa, Chun Wang, Zhenchao Zhang, Rui Luo, Weelic Chong, Daniel P. Silver, Frederick Fellin, Rebecca Jaslow, AnaMaria Lopez, Terrence Cescon,
and et al. 2022. "Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism" Cancers 14, no. 12: 2872.
https://doi.org/10.3390/cancers14122872
APA Style
Abu-Khalaf, M., Wang, C., Zhang, Z., Luo, R., Chong, W., Silver, D. P., Fellin, F., Jaslow, R., Lopez, A., Cescon, T., Jiang, W., Myers, R., Wei, Q., Li, B., Cristofanilli, M., & Yang, H.
(2022). Genomic Aberrations in Circulating Tumor DNAs from Palbociclib-Treated Metastatic Breast Cancer Patients Reveal a Novel Resistance Mechanism. Cancers, 14(12), 2872.
https://doi.org/10.3390/cancers14122872